Access
To read this story in full you will need to login or make a payment (see right).
Insight
Nature 451, 904-913 (21 February 2008) | doi:10.1038/nature06796; Published online 20 February 2008
Review Article Translating molecular discoveries into new therapies for atherosclerosis
Daniel J. Rader1 & Alan Daugherty2
Abstract
Atherosclerosis is characterized by the thickening of the arterial wall and is the primary cause of coronary artery disease and cerebrovascular disease, two of the most common causes of illness and death worldwide. Clinical trials have confirmed that certain lipoproteins and the renin–angiotensin–aldosterone system are important in the pathogenesis of atherosclerotic cardiovascular disease, and that interventions targeted towards these are beneficial. Furthermore, efforts to understand how risk factors such as high blood pressure, dysregulated blood lipids and diabetes contribute to atherosclerotic disease, as well as to understand the molecular pathogenesis of atherosclerotic plaques, are leading to new targets for therapy.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
The clot thickens?oxidized lipids and thrombosisNature Medicine News and Views (01 Sep 2007)
Thrombogenesis linked to atherogenesis at last?Nature News and Views (07 Sep 1989)